MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Intermediaries
Intermediaries: Triple Helix Regional Innovation Clusters (RIC)s
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
*Industry: Ireland
Jazz Pharmaceuticals plc (NASDAQ: JAZZ)*
Finance & Acquisitions: Jazz Pharmaceuticals
Chimerix Inc. (NASDAQ:CMRX)*
Organization & Developments: Chimerix
Parents
Chimerix Inc. (NASDAQ:CMRX)*
Children
*Chimerix has also recently completed a phase I study of CMX157, which is being developed as a treatment for HIV infections, including those infections caused by multi-drug resistant viruses.
*Chimerix is also developing programs in CMV and HIV
*Chimerix’s lead drug candidate is CMX001, which is being developed as a broad-spectrum antiviral for life-threatening diseases. The compound also has potential as a medical countermeasure to smallpox.
*Lipid prodrug technology to improve the efficacy of antiviral drugs.
*The Company's lead compound, CMX001, is an active agent against the smallpox virus.
2021: Chimerix: Recent Acquisition Gives This Laggard Antiviral Company A Fresh Start In Oncology
2022: Chimerix: Big Doings At A Small Biotech_seekingalpha.com
2024: Chimerix faces Nasdaq delisting over share price woes By Investing.com
2024: Chimerix to File FDA Application for Breakthrough Brain Cancer Drug with 28% Response Rate
2024: Chimerix: Big News, Big Moves, So Maybe Now's The Time To Buy_seekingalpha.com
2024: Chimerix: Tackling A Strong Unmet Need With Promising Data
2025: Chimerix gains on FDA review for brain tumor drug_ seekingalpha.com
2025: Chimerix: Potential 'First' In Targeting Recurrent High-Grade Glioma Patients
Jumps
*Key People: Chimerix
Finance & Acquisition: Chimerix